Don't just focus on the K-line! Companies listed on the New York Stock Exchange are currently ‘openly’ accumulating $INJ , do you still not understand?
In the cryptocurrency market, retail investors are often the last to know the news. However, if we learn to track the movements of the ‘whales’, we can often position ourselves for the next hundredfold opportunity in advance. Recently, a significant signal caught my attention: the New York Stock Exchange-listed company Pineapple Financial announced the establishment of a $100 million digital asset treasury.
This is not just a numbers game; they are continuously buying on the open market $INJ .
Why @Injective ?
The selection logic of institutions is completely different from that of retail investors. They do not pay attention to memes, nor do they focus on short-term speculation; they look at compliance, infrastructure, and long-term value. Injective, as a Layer-1 built specifically for finance, has its ‘institution-friendly’ attributes ingrained in its DNA. Pineapple Financial's entry essentially represents a ‘vote’ for Injective as the future on-chain financial infrastructure.
What does this mean?
When a publicly listed company starts to treat a certain token as part of its balance sheet, it not only provides significant buying support but also sends a strong signal: traditional finance is embracing Injective. It's akin to when MicroStrategy began buying Bitcoin, marking a watershed moment.
If you are still hesitating whether the current price is suitable, think about why these publicly listed companies with top-tier investment research teams are willing to enter the market at this position? Following smart money is often the strategy with the highest win rate.
DYOR
